The Biden administration on Thursday asserted its authority to seize the patents of certain costly medications in a new push to slash high drug prices and promote more pharmaceutical competition.

The administration unveiled a framework outlining the factors federal agencies should consider in deciding whether to use a controversial policy, known as march-in rights, to break the patents of drugs that were developed with federal funds but are not widely accessible to the public. For the first time, officials can now factor in a medication’s price — a change that could have big implications for drugmakers depending on how the government uses the powers.

“When drug companies won’t sell taxpayer-funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House National Economic Advisor Lael Brainard said during a call with reporters Wednesday.

  • Cheems@lemmy.world
    link
    fedilink
    arrow-up
    2
    ·
    11 months ago

    Does anyone really see those ads then go to a DOCTOR and ask about it? Maybe I’m in the extreme minority here but I don’t have money burning a hole in my pocket to go to a doctor and if I do I want to spend the absolute least as possible

    • psud@aussie.zone
      link
      fedilink
      arrow-up
      2
      ·
      11 months ago

      Yes they do, but also the doctors get advertised at too and pick medications for you that the marketers have recommended, regardless of whether it’s the best treatment